BB Biotech Investor Relations Material
Latest events
Q1 2025
25 Apr, 2025
Q4 2024
21 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BB Biotech AG
Access all reports
BB Biotech AG is an investment company specializing in biotechnology. The company focuses on building a diversified portfolio of publicly listed biotech companies, primarily in the fields of drug development and medical research. BB Biotech's investments target companies involved in innovative treatments for diseases across therapeutic areas such as oncology, rare diseases, and infectious diseases. The company is headquartered in Schaffhausen, Switzerland, and its shares are listed on the SIX.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
BION
Country
🇨🇭 Switzerland